ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Novavax Inc

Novavax Inc (NVAX)

8,00
0,17
(2,17%)
Geschlossen 20 November 10:00PM
7,98
-0,02
(-0,25%)
Nach Börsenschluss: 1:59AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
7,98
Gebot
7,95
Fragen
7,97
Volumen
4.253.691
7,6501 Tagesbereich 8,10
3,5324 52-Wochen-Bereich 23,8599
Marktkapitalisierung
Handelsende
7,83
Handelsbeginn
7,80
Letzte Trade
2
@
7.96
Letzter Handelszeitpunkt
Finanzvolumen
US$ 33.641.522
VWAP
7,9088
Durchschnittliches Volumen (3 Mio.)
6.438.004
Ausgegebene Aktien
160.093.639
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,35
Gewinn pro Aktie (EPS)
-3,4
Erlöse
983,71M
Nettogewinn
-545,06M

Über Novavax Inc

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to res... Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Novavax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NVAX. The last closing price for Novavax was US$7,83. Over the last year, Novavax shares have traded in a share price range of US$ 3,5324 to US$ 23,8599.

Novavax currently has 160.093.639 shares in issue. The market capitalisation of Novavax is US$1,25 billion. Novavax has a price to earnings ratio (PE ratio) of -2.35.

Option-Flow Novavax (NVAX)

Gesamtfluss

Bullisch

Nettoprämie

3k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

50,00%

NVAX Neueste Nachrichten

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) PR Newswire GAITHERSBURG, Md., Nov. 15, 2024 GAITHERSBURG, Md., Nov. 15, 2024 /PRNewswire/ -- Novavax, Inc...

Novavax to Participate in Jefferies London Healthcare Conference

Novavax to Participate in Jefferies London Healthcare Conference PR Newswire GAITHERSBURG, Md., Nov. 13, 2024 GAITHERSBURG, Md., Nov. 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a...

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., Nov. 12, 2024 U.S. FDA removes clinical hold on Investigational New Drug application...

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial PR Newswire GAITHERSBURG, Md., Nov. 11, 2024 GAITHERSBURG, Md., Nov. 11, 2024...

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 PR Newswire GAITHERSBURG, Md., Nov. 4, 2024 GAITHERSBURG, Md., Nov...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.02-0.2588.96.8184895467.74123253CS
4-2.16-21.301775147910.1410.636.8156877218.83061605CS
12-3.45-30.183727034111.4315.226.81643800411.25651292CS
26-5.02-38.61538461541323.85996.81876750613.88486995CS
522.2338.78260869575.7523.85993.5324948435310.2322818CS
156-184.61-95.8564826834192.59236.53.5324751072325.39517393CS
2604.11106.2015503883.87331.53883.5324675095054.21776358CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PRFXPainReform Ltd
US$ 1,35
(152,34%)
195,81M
NCNCnoco noco Inc
US$ 0,1652
(70,31%)
767,43M
NXTTNext Technology Holding Inc
US$ 2,7699
(62,94%)
3,73M
SMCXDefiance Daily Target 2X Long SMCI ETF
US$ 41,475
(62,52%)
4,18M
TRNRInteractive Strength Inc
US$ 3,93
(55,34%)
25,79M
SLNSilence Therapeutics PLC
US$ 6,99
(-36,57%)
4,53M
AKTXAkari Therapeutics PLC
US$ 1,57
(-31,44%)
316,64k
QMMMQMMM Holdings Limited
US$ 1,25
(-27,75%)
4,54M
DMNDamon Inc
US$ 1,75
(-27,39%)
992,36k
GDHGGolden Heaven Group Holdings Ltd
US$ 1,50
(-26,47%)
316,77k
NCNCnoco noco Inc
US$ 0,1652
(70,31%)
767,43M
SYRSSyros Pharmaceuticals Inc
US$ 0,2718
(36,72%)
365,79M
WBUYWeBuy Global Ltd
US$ 0,1931
(21,37%)
254,22M
SMCISuper Micro Computer Inc
US$ 28,30
(31,38%)
235,26M
NVDANVIDIA Corporation
US$ 147,01
(4,89%)
227,85M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock